Consultation: long-term azithromycin in respiratory disease

Following development in Bury and adaptation for implementation across the ICB, we now seek comments on draft guidance for long-term azithromycin for chronic respiratory conditions.

All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.

Please note

1. The messages sent from this form are transmitted via our host’s web server. If you have any security concerns about this process you can send your comments/feedback using your own email client to nuth.enquiries.gmmmg@nhs.net.
2. This consultation closes at 5pm on Wednesday 7th June 2023.

Name *

First

Last

Email *

Email

Confirm Email

Your job title *

Your employer *

Locality

Are you responding on behalf of an organisation or as an individual? *

• On behalf of an organisation or organisational leader
• As an individual

Please specify who you are responding for, including job title and organisation as appropriate *

Do you support implementation of the pathway?

• Yes
• No (please provide detail below)
• In part (please provide detail below)

If no or "in part", please explain why

What local pathways are in place for the management of patients prescribed long-term azithromycin for respiratory conditions and do these differ depending on the condition being treated?

Do you have any additional comments?

Submit